APA (7th ed.) Citation

N, S., N, S., & W, N. (2026). Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89". Current oncology (Toronto, Ont.), 33(5), . https://doi.org/10.3390/curroncol33050248

Chicago Style (17th ed.) Citation

N, Sae-Sim, Samarnthai N, and Numprasit W. "Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim Et Al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89"." Current Oncology (Toronto, Ont.) 33, no. 5 (2026). https://doi.org/10.3390/curroncol33050248.

MLA (9th ed.) Citation

N, Sae-Sim, et al. "Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim Et Al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89"." Current Oncology (Toronto, Ont.), vol. 33, no. 5, 2026, https://doi.org/10.3390/curroncol33050248.